Publication Spotlight: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Sep 3rd 2024
The IBL-America Enzyme-linked Immunosorbent Assay (ELISA) for Angiotensinogen (Total) was used in this study.27412Akshay S. Desai, M.D., M.P.H., David J. Webb, M.D., D.Sc., Jorg Taubel, M.D., Sarah Ca
… read more